Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 12701 - 12725 of 13388 in total
Experimental
Matched Iupac: … 2-(piperidin-1-yl)ethyl [1,1'-bi(cyclohexane)]-1-carboxylate …
Experimental
Matched Iupac: … N-[2-(dibutylamino)ethyl]-3-phenyl-1,2,4-oxadiazol-5-amine …
Matched Categories: … Heterocyclic Compounds, 1-Ring …
Experimental
Matched Iupac: … gold(1+) ion sodium 2-hydroxy-3-sulfanidylpropane-1-sulfonate …
Centanafadine is under investigation in clinical trial NCT02827513 (A Phase 1 Study to Investigate the Safety, Tolerance, Food Effect, Pharmacokinetics and Pharmacodynamics of Single and Multiple Doses of Extended Release Formulations of Centanafadine (CTN) in Young Healthy Subjects).
Investigational
Matched Iupac: … (1R,5S)-1-(naphthalen-2-yl)-3-azabicyclo[3.1.0]hexane …
Matched Description: … Centanafadine is under investigation in clinical trial NCT02827513 (A Phase 1 Study to Investigate the …
Ansofaxine is under investigation in clinical trial NCT02271412 (Multiple Ascending Dose Study in Healthy Subjects to Evaluate the Safety, Tolerability, and Pharmacokinetics of LY03005).
Investigational
Matched Iupac: … 4-[2-(dimethylamino)-1-(1-hydroxycyclohexyl)ethyl]phenyl 4-methylbenzoate …
Experimental
Matched Iupac: … 2-[(4-chloronaphthalen-1-yl)methyl]-4,5-dihydro-1H-imidazole …
Idraparinux, a synthetic pentasaccharide is an antithrombin-dependent inhibitor of activated factor X. It was developed for the treatment and prevention of thromboembolic events. However, clinical trials have revealed that idraparinux had lead to bleeding. As a result, Sanofi stopped the development of the drug.
Investigational
Matched Iupac: … )-6-methoxy-4,5-bis(sulfooxy)-2-[(sulfooxy)methyl]oxan-3-yl]oxy}oxan-3-yl]oxy}-4,5-bis(sulfooxy)-2-[( ... ]oxan-2-yl]oxy}oxane-2-carboxylic acid ... sulfooxy)methyl]oxan-3-yl]oxy}-4,5-dimethoxy-3-{[(2R,3R,4S,5R,6R)-3,4,5-trimethoxy-6-[(sulfooxy)methyl ... (2S,3S,4S,5R,6R)-6-{[(2R,3R,4S,5R,6R)-6-{[(2R,3S,4S,5R,6R)-2-carboxy-4,5-dimethoxy-6-{[(2R,3R,4S,5R,6S …
Experimental
Matched Iupac: … (2R,3R,4S,5S,6R)-2-{[(2R,3S,4R,5R,6R)-4,5-dihydroxy-2-(hydroxymethyl)-6-(undecyloxy)oxan-3-yl]oxy}-6- …
OBP-801 has been used in trials studying the treatment of Solid Tumor.
Investigational
Matched Iupac: … (1S,5S,6R,9S,15E,20R)-5-hydroxy-20-methyl-6-(propan-2-yl)-2-oxa-11,12-dithia-7,19,22-triazabicyclo[7.7.6 …
BMS-813160 is under investigation in clinical trial NCT03496662 (BMS-813160 With Nivolumab and Gemcitabine and Nab-paclitaxel in Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma (PDAC)).
Investigational
Matched Iupac: … N-[(1R,2S,5R)-5-(tert-butylamino)-2-[(3S)-3-({7-tert-butylpyrazolo[1,5-a][1,3,5]triazin-4-yl}amino)-2 ... -oxopyrrolidin-1-yl]cyclohexyl]acetamide …
Matched Categories: … Heterocyclic Compounds, 1-Ring …
Carfentanil or carfentanyl (Wildnil) is an analogue of the popular synthetic opioid analgesic fentanyl, and is one of the most potent opioids known (also the most potent opioid used commercially). Carfentanil was first synthesized in 1974 by a team of chemists at Janssen Pharmaceutica which included Paul Janssen. It has...
Illicit
Investigational
Vet approved
Matched Iupac: … methyl 1-(2-phenylethyl)-4-(N-phenylpropanamido)piperidine-4-carboxylate …
Matched Description: … 10,000 times that of morphine and 100 times that of fentanyl, with activity in humans starting at about 1
Matched Categories: … Heterocyclic Compounds, 1-Ring …
Experimental
Matched Iupac: … (2S,3S,4S,5S,6S)-3,4,5,6-tetrahydroxyoxane-2-carboxylic acid …
Experimental
Matched Iupac: … 2lambda5-triaz-1-en-2-yn-1-ide hydrate diiron …
Experimental
Matched Iupac: … 4-[(1E)-2-carboxyeth-1-en-1-yl]benzoic acid …
Experimental
Matched Iupac: … [(2R)-2,3-bis(dodecanoyloxy)propoxy][2-(trimethylazaniumyl)ethoxy]phosphinic acid …
Experimental
Matched Iupac: … (2S,3R,4S,5R,6R)-3,4,5,6-tetrahydroxyoxane-2-carboxylic acid …
Experimental
Matched Iupac: … (2S)-2-amino-3-{[1,1'-biphenyl]-4-yl}propanoic acid …
Experimental
Matched Iupac: … (2R)-2-amino-3-[(3-aminopropyl)sulfanyl]propan-1-ol …
Talinolol has been investigated for the basic science of Gastrointestinal Motility Disorder.
Investigational
Matched Iupac: … 3-{4-[3-(tert-butylamino)-2-hydroxypropoxy]phenyl}-1-cyclohexylurea …
Pilsicainide has been investigated for the treatment of Paroxysmal Atrial Fibrillation.
Investigational
Matched Iupac: … N-(2,6-dimethylphenyl)-2-(hexahydro-1H-pyrrolizin-7a-yl)acetamide …
Matched Salts cas: … 88069-49-2
Magnesium orotate is a magnesium salt of orotic acid and is poorly soluble in water. It is a source of magnesium and is used as a mineral supplement to treat Mg deficiency. Orotic acid acts as a transporter that carries magnesium into the cells. It also exhibits antioxidant properties, since...
Experimental
Matched Iupac: … magnesium(2+) ion bis(2,6-dioxo-1,2,3,6-tetrahydropyrimidine-4-carboxylate) …
Matched Categories: … Heterocyclic Compounds, 1-Ring …
Experimental
Matched Iupac: … 10-[3-(dimethylamino)-2-methylpropyl]-10H-5lambda6-phenothiazine-5,5-dione …
Matched Categories: … Heterocyclic Compounds, 3-Ring …
Experimental
Matched Iupac: … 4-(7-bromo-5-methoxy-1-benzofuran-2-yl)piperidine …
Matched Categories: … Heterocyclic Compounds, 1-Ring …
Histamine glutarimide is under investigation in clinical trial NCT03450434 (XC8 in the Treatment of Patients With Bronchial Asthma).
Investigational
Matched Iupac: … 1-[2-(1H-imidazol-5-yl)ethyl]piperidine-2,6-dione …
Matched Categories: … Heterocyclic Compounds, 1-Ring …
Nepadutant has been used in trials studying the treatment of Colic, Infantile Colic, and Infantile Functional Gastrointestinal Disorders.
Investigational
Matched Iupac: … 2-[(1S,4S,7S,10S,13S,16S)-4-benzyl-7-[(1H-indol-3-yl)methyl]-16-(2-methylpropyl)-3,6,9,12,15,18,21-heptaoxo ... -6-(hydroxymethyl)oxan-2-yl]acetamide ... -2,5,8,11,14,17,20-heptaazabicyclo[8.8.4]docosan-13-yl]-N-[(2R,3R,4R,5S,6R)-3-acetamido-4,5-dihydroxy …
Displaying drugs 12701 - 12725 of 13388 in total